21 results on '"Durkin M"'
Search Results
2. PDB38 REAL-WORLD COMPARISON OF HOSPITALIZATION COSTS FOR HEART FAILURE IN T2DM PATIENTS WITH CARDIOVASCULAR DISEASE TREATED WITH CANAGLIFLOZIN VERSUS OTHER ANTIHYPERGLYCEMIC AGENTS
3. Characterization of Patient Activation, Clinical Assessments, and Patient Reported Outcomes in T2DM Patients
4. The Long-Term Benefits of Ensuring Timely Treatment and Improved Medication Adherence in Early Schizophrenia: A Microsimulation Study
5. PMH52 - The Long-Term Benefits of Ensuring Timely Treatment and Improved Medication Adherence in Early Schizophrenia: A Microsimulation Study
6. PDB67 - Characterization of Patient Activation, Clinical Assessments, and Patient Reported Outcomes in T2DM Patients
7. Assessing the impact of varying threshold criteria for Opioid Overutilization
8. An Evaluation Of Opioid Overutilization Quality Metrics Using Receiver Operating Characteristic Curves And Proxies For Overutilization
9. Factors associated with performance on the medicaid hedis measure: Continuity of antipsychotic (AP) medications for treatment of schizophrenia
10. PMH84 Validity of Administrative Claims Data for Calculating Adherence Measures for Long-Acting Injectable (Lai) Antipsychotic Therapies
11. PMH51 Attributes Associated with a Preference for Monthly Injectable Therapy in Patients with Schizophrenia
12. PSY85 - Assessing the impact of varying threshold criteria for Opioid Overutilization
13. PMH85 PATTERNS OF AUGMENTATION OF EXTENDED-RELEASE STIMULANTS FOR ADHD WITH IMMEDIATE-RELEASE STIMULANTS IN CHILDREN AND ADOLESCENTS
14. PMH82 PATTERNS OF AUGMENTATION OF EXTENDED-RELEASE STIMULANTS FOR ADHD WITH IMMEDIATE-RELEASE STIMULANTS IN ADULTS
15. MH3 PREVALENCE OF LIVER DISEASES IN MEDICAID RECIPIENTS WITH SCHIZOPHRENIA
16. PSY79 - An Evaluation Of Opioid Overutilization Quality Metrics Using Receiver Operating Characteristic Curves And Proxies For Overutilization
17. PMH58 - Factors associated with performance on the medicaid hedis measure: Continuity of antipsychotic (AP) medications for treatment of schizophrenia
18. PGI3 IMPACT OF PROTON PUMP INHIBITOR UTILIZATION PATTERNS ON GASTROESOPHAGEAL REFLUX DISEASE-RELATED COSTS
19. PMH26 A COMPARISON OF RISPERIDONE AND OLANZAPINE MENTAL HEALTH COSTS FOR MANAGED CARE PATIENTS WITH SCHIZOPHRENIA
20. PNP4 PRESCRIBING PATTERNS OF LONG-ACTING OPIOIDS FOR CHRONIC NON-MALIGNANT PAIN IN THE VETERANS ADMINISTRATION SYSTEM
21. PNP14: COST AND UTILIZATION OUTCOMES OF PATIENTS TREATED FOR SCHIZOPHRENIA IN A MEDICAID POPULATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.